Literature DB >> 3973405

Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.

B Aronsson, R Möllby, C E Nord.   

Abstract

The carrier rate of Clostridium difficile in an adult Swedish population was found to be 11 (1.9%) of 594. All isolates were toxigenic in vitro, but no healthy individual harbored free cytotoxin in stool. Of 398 patients with acute diarrhea not associated with antibiotic use, cytotoxin was found in stool filtrates of four (1%). In 4,793 patients with antibiotic-associated diarrhea from all parts of Sweden during 1980-1982, C. difficile cytotoxin was demonstrated in 873 (18%). The tissue culture assay was found to be more specific than cultivation for the bacterium. By weighted analysis, in the age group greater than 70 years more women than men were infected. In the age group 21-50 years there was an even greater preponderance of infection in women than in men. Cephalosporins and lincosamides were 10-70 times more often implicated in C. difficile colitis than were narrow-spectrum penicillins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973405     DOI: 10.1093/infdis/151.3.476

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  54 in total

1.  Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo.

Authors:  M C Barc; C Depitre; G Corthier; A Collignon; W J Su; P Bourlioux
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 2.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

Review 3.  Clostridium difficile associated diarrhoea: diagnosis and treatment.

Authors:  John Starr
Journal:  BMJ       Date:  2005-09-03

4.  Detection of Clostridium difficile toxin by enzyme immunoassay, tissue culture test and culture.

Authors:  O Liesenfeld; F Saeger; H Hahn
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

5.  Clostridium difficile-associated diarrhoea in uremic patients.

Authors:  B Aronsson; P Barany; C E Nord; B Nyström; P Stenvinkel
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

6.  Three-year prevalence of enteropathogenic bacteria in an urban patient population in Germany.

Authors:  O Liesenfeld; T Weinke; H Hahn
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

Review 7.  Adverse reactions and interactions with newer cephalosporin and cephamycin antibiotics.

Authors:  S R Norrby
Journal:  Med Toxicol       Date:  1986 Jan-Feb

8.  Clostridium difficile in urology.

Authors:  M Hossain; T J Crook; S R Keoghane
Journal:  Ann R Coll Surg Engl       Date:  2008-01       Impact factor: 1.891

9.  Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea.

Authors:  M T Kelly; S G Champagne; C H Sherlock; M A Noble; H J Freeman; J A Smith
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

10.  Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.

Authors:  M Warny; J P Vaerman; V Avesani; M Delmée
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.